Clinical Trials Logo

Myocardial Failure clinical trials

View clinical trials related to Myocardial Failure.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04698954 Completed - Clinical trials for Chronic Heart Failure

Evaluating the Adherence Improving Self-Management Strategy Intervention in Chronic Heart Failure Patients

AIMS-CHF RCT
Start date: December 14, 2020
Phase: N/A
Study type: Interventional

Patient non-adherence to treatment recommendations is common and decreases the effectiveness of Chronic Heart Failure (CHF) treatment. Improving adherence towards medication intake, physical activity, symptom monitoring/management might prolong life, alleviates symptoms, increases quality of life, and reduces hospital admissions. The Adherence Improving self-management Strategy (AIMS) is a nurse delivered intervention, integrated in routine clinical care, aiming to better support patients in their treatment. AIMS has previously been demonstrated to be (cost) effective amongst HIV patients. Based on the literature and advisory boards with healthcare providers and CHF patients, AIMS is adapted to CHF (AIMS-CHF). The aim of the study is to evaluate the effectiveness of the AIMS intervention on adherence regarding medication, physical activity, and symptom management compared to treatment-as-usual in patients with chronic heart failure.

NCT ID: NCT03855982 Completed - Myocarditis Clinical Trials

Monitoring Drug-induced Myocarditis (CardiTOX)

CardiTOX
Start date: April 9, 2019
Phase:
Study type: Observational

Several drugs and chemotherapies seem to induce myocarditis. This study investigates reports of myocarditis, including the International classification of disease ICD-10 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).

NCT ID: NCT03730961 Completed - Clinical trials for Congestive Heart Failure

An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic

Start date: January 17, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate continuous 8-hour introductions of BMS-986231 in participants with heart failure and weakened heart function given a standard dose of diuretic.

NCT ID: NCT03634969 Completed - Cardiac Failure Clinical Trials

An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants

Start date: August 14, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the experimental medication BMS-986224 in participants with varying levels of renal function.

NCT ID: NCT03515980 Completed - Clinical trials for Congestive Heart Failure

An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function

Start date: May 25, 2018
Phase: Phase 1
Study type: Interventional

This is an investigational study of experimental Medication BMS-986231 given to participants with weakened or damaged liver function.

NCT ID: NCT03332186 Completed - Clinical trials for Congestive Heart Failure

A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function

Start date: March 15, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate experimental medication BMS-986231 in patients with different levels of kidney function.